Skip to content
Screener

LivaNova LIVN Other income, net (Note 6)

Other income, net (Note 6) at other companies

Haemonetics logo
HaemoneticsHAE
-$9.88M-13.6%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$165K-101%
Inspire Medical Systems logo
Inspire Medical SystemsINSP
-$226K-139%
ITG
Integer HoldingsITGR
-$316K+99.3%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$12.02M+4,145%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$390.6M+10.8%
Gross profit$273.7M+14.5%
Operating income$49.5M-8.7%
Net income$108.6M+300%
EPS (diluted)$1.93+286%

Balance sheet

See full
Cash & equivalents$516.6M-13.0%
Total debt$348.5M-27.8%
Total equity$1.3B+18.0%
Total assets$2.6B+5.4%

Cash flow

See full
Operating cash flow$66.6M+5.8%
CapEx$31.6M+108%
Free cash flow$35.0M-26.7%

Valuation

See full
Market cap$4.17B+61.5%
Enterprise value$4.01B+61.9%
P/E22.6×-67.9×
P/S2.8×+0.9×

Profitability

See full
Gross margin68.1%+0.1pp
Operating margin12.7%-0.7pp
Net margin-16.1%-18.0pp
FCF margin10.1%-2.3pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.2×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: LivaNova’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 2:23 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001639691-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest income3,8314,1837,38310,626
FX fluctuations(779)(1,240)(1,368)(1,850)
Impairment of investment(1,132)
Investment revaluation - Ceribell, Inc. (3)(1,008)(3,622)
Fair value adjustment - 2025 Embedded Derivative (1)(489)1,552
Fair value adjustment - 2025 Capped Calls (1)498(1,321)
Other105200203127
$(23,829)$(4,255)$(29,524)$7,161

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is LivaNova's other income, net (note 6)?
LivaNova (LIVN) reported other income, net (note 6) of $105K in Q2 2026.
How has LivaNova's other income, net (note 6) changed year-over-year?
LivaNova's other income, net (note 6) decreased by 47.5% year-over-year, from $200K to $105K.
What is the long-term trend for LivaNova's other income, net (note 6)?
Over 2 years (2022 to 2025), LivaNova's other income, net (note 6) has grown at a -2.0% compound annual growth rate (CAGR), from $691K to $664K.
What does other income, net (note 6) mean?
This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.

Ask your AI about LivaNova's other income, net (note 6).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude